COVID-19 Pandemic and Vaccine Imperialism

被引:0
作者
Seretis, Stergios A. [1 ]
Mavroudeas, Stavros D. [2 ]
Tanik, Feride Aksu [3 ]
Benos, Alexios [4 ]
Kondilis, Elias [4 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Med, Sch Med, Univ Campus, Thessaloniki, Greece
[2] Pante Univ Social & Polit Sci, Social Policy, 136 Syggrou Ave, Athens 17671, Greece
[3] Ege Univ, Fac Med, Dept Publ Hlth, Izmir, Turkiye
[4] Aristotle Univ Thessaloniki, Sch Med, Fac Hlth Sci, Thessaloniki, Greece
关键词
COVID-19; pandemic; vaccination; vaccination inequalities; intellectual property rights; vaccine imperialism; HEALTH; GLOBALIZATION; ECONOMY; FUTURE;
D O I
10.1177/04866134241282107
中图分类号
F [经济];
学科分类号
02 ;
摘要
The COVID-19 pandemic revealed and exacerbated the global inequalities regarding the availability and access to vaccines. Many terms have appeared in the academic literature ("vaccine colonialism," "vaccine nationalism," "vaccine apartheid") trying to capture and interpret these inequalities, failing in most cases to realistically explain the upstream causes of the observed injustices. A Marxist perspective on the contrary emphasizes the structural causes of inequalities in capitalism and attributes them to the existence of economic exploitation. "Vaccine imperialism," which refers to the control that advanced industrialized countries exert on the development, production, and distribution of vaccines at the expense of less-developed economies, can describe and explain in a more realistic way the observed inequalities during the pandemic. Our study proposes a circuit of vaccine imperialism that explains how economic imperialist exploitation takes place via transfers of value from less-developed economies (vaccine recipient countries) to imperialist economies (vaccine producing and patent holder countries) using four different channels: (a) protection of intellectual property (IP) rights (patents), (b) earnings from royalty payments for the use of vaccines (monopolistic prices and profits), (c) exercise of monopoly power on the production and distribution of vaccines (control over the quantity of vaccines supplied, exclusion of competitors through vaccine licensing), and (d) public debt servicing.
引用
收藏
页码:9 / 29
页数:21
相关论文
共 100 条
[31]   To what extent patents for Covid-19 mRNA vaccines are based on public research and taxpayers' funding? A case study on the privatization of knowledge [J].
Florio, Massimo .
INDUSTRIAL AND CORPORATE CHANGE, 2022, 31 (05) :1137-1151
[32]   AstraZeneca's covid-19 (mis)adventure and the future of vaccine equity [J].
Fortner, Robert .
BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
[33]  
Global Health Centre, 2021, COVID-19 Vaccines Research and Development Investments
[34]  
Greer S. L., 2020, Eurohealth, V26, P104
[35]   COVAX can still end COVID-19 vaccine apartheid [J].
Gupta, Anuradha .
NATURE HUMAN BEHAVIOUR, 2022, 6 (02) :175-175
[36]   Strategic Patenting by Pharmaceutical Companies - Should Competition Law Intervene? [J].
Gurgula, Olga .
IIC-INTERNATIONAL REVIEW OF INTELLECTUAL PROPERTY AND COMPETITION LAW, 2020, 51 (09) :1062-1085
[37]   Coloniality of Waithood: Africa's Wait for COVID-19 Vaccines amid COVAX and TRIPS [J].
Hagan, Ampson .
AFRICAN STUDIES REVIEW, 2023, 66 (02) :327-351
[38]   Global vaccine equity demands reparative justice - not charity [J].
Harman, Sophie ;
Erfani, Parsa ;
Goronga, Tinashe ;
Hickel, Jason ;
Morse, Michelle ;
Richardson, Eugene T. .
BMJ GLOBAL HEALTH, 2021, 6 (06)
[39]   Against vaccine nationalism [J].
Hassoun, Nicole .
JOURNAL OF MEDICAL ETHICS, 2021, 47 (11) :773-774
[40]   The end of the old order? Globalization and the prospects for world order [J].
Held, D ;
McGrew, A .
REVIEW OF INTERNATIONAL STUDIES, 1998, 24 :219-243